Class of 2025
For invaluable contributions to cancer screening, prevention, and survivorship in underserved and high-risk populations for breast, cervical, and colorectal cancer, as well as for seminal studies that established aspirin’s role in preventing colorectal adenomas and duloxetine’s impact on improving patient quality of life following chemotherapy.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]